290 related articles for article (PubMed ID: 19058876)
1. Costs associated with hospital-acquired bacteraemia in an Indian hospital: a case-control study.
Kothari A; Sagar V; Ahluwalia V; Pillai BS; Madan M
J Hosp Infect; 2009 Feb; 71(2):143-8. PubMed ID: 19058876
[TBL] [Abstract][Full Text] [Related]
2. Costs associated with hospital-acquired bacteraemia in a Belgian hospital.
Pirson M; Dramaix M; Struelens M; Riley TV; Leclercq P
J Hosp Infect; 2005 Jan; 59(1):33-40. PubMed ID: 15571851
[TBL] [Abstract][Full Text] [Related]
3. Comparative impact of hospital-acquired infections on medical costs, length of hospital stay and outcome between community hospitals and medical centres.
Sheng WH; Wang JT; Lu DC; Chie WC; Chen YC; Chang SC
J Hosp Infect; 2005 Mar; 59(3):205-14. PubMed ID: 15694977
[TBL] [Abstract][Full Text] [Related]
4. Cost of intensive care unit-acquired bloodstream infections.
Laupland KB; Lee H; Gregson DB; Manns BJ
J Hosp Infect; 2006 Jun; 63(2):124-32. PubMed ID: 16621137
[TBL] [Abstract][Full Text] [Related]
5. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital.
Warren DK; Quadir WW; Hollenbeak CS; Elward AM; Cox MJ; Fraser VJ
Crit Care Med; 2006 Aug; 34(8):2084-9. PubMed ID: 16763511
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation after cardiothoracic surgery.
Gillespie EL; White CM; Kluger J; Rancourt JA; Gallagher R; Coleman CI
Pharmacotherapy; 2006 Apr; 26(4):499-504. PubMed ID: 16553508
[TBL] [Abstract][Full Text] [Related]
7. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections.
Blot SI; Depuydt P; Annemans L; Benoit D; Hoste E; De Waele JJ; Decruyenaere J; Vogelaers D; Colardyn F; Vandewoude KH
Clin Infect Dis; 2005 Dec; 41(11):1591-8. PubMed ID: 16267731
[TBL] [Abstract][Full Text] [Related]
8. Financial consequences of hospital-acquired bacteraemia in three Belgian hospitals in 2003 and 2004.
Pirson M; Leclercq P; Jackson T; Leclercq M; Garrino M; Sion C
J Hosp Infect; 2008 Jan; 68(1):9-16. PubMed ID: 18055065
[TBL] [Abstract][Full Text] [Related]
9. [Study of costs associated with catheter-related bacteremia].
Morís de la Tassa J; Fernández Muñoz P; Antuña Egocheaga A; Gutiérrez del Río MC; de la Fuente García B; Cartón Sánchez JA
Rev Clin Esp; 1998 Oct; 198(10):641-6. PubMed ID: 9844450
[TBL] [Abstract][Full Text] [Related]
10. [Bacteraemia at a second level hospital: epidemiological study, analysis of pronostic factors associated to mortality and economic cost estimation].
Hernández-Roca JJ; García-Vázquez E; Hernández A; Canteras M; Herrero JA; Cascales E; Mené-Fenor E; Gómez-Gómez J
Rev Esp Quimioter; 2013 Jun; 26(2):119-27. PubMed ID: 23817650
[TBL] [Abstract][Full Text] [Related]
11. Hospital-acquired, laboratory-confirmed bloodstream infections: linking national surveillance data to clinical and financial hospital data to estimate increased length of stay and healthcare costs.
Vrijens F; Hulstaert F; Van de Sande S; Devriese S; Morales I; Parmentier Y
J Hosp Infect; 2010 Jul; 75(3):158-62. PubMed ID: 20381900
[TBL] [Abstract][Full Text] [Related]
12. Mortality rate, length of stay and extra cost of sternal surgical site infections following coronary artery bypass grafting in a private medical centre in Turkey.
Coskun D; Aytac J; Aydinli A; Bayer A
J Hosp Infect; 2005 Jun; 60(2):176-9. PubMed ID: 15866018
[TBL] [Abstract][Full Text] [Related]
13. Healthcare-associated Staphylococcus aureus bloodstream infection: length of stay, attributable mortality, and additional direct costs.
Primo MG; Guilarde AO; Martelli CM; Batista LJ; Turchi MD
Braz J Infect Dis; 2012; 16(6):503-9. PubMed ID: 23158266
[TBL] [Abstract][Full Text] [Related]
14. Attributable mortality rate and duration of hospital stay associated with enterococcal bacteremia.
Caballero-Granado FJ; Becerril B; Cuberos L; Bernabeu M; Cisneros JM; Pachón J
Clin Infect Dis; 2001 Feb; 32(4):587-94. PubMed ID: 11181122
[TBL] [Abstract][Full Text] [Related]
15. The attributable cost and length of hospital stay because of nosocomial pneumonia in intensive care units in 3 hospitals in Argentina: a prospective, matched analysis.
Rosenthal VD; Guzman S; Migone O; Safdar N
Am J Infect Control; 2005 Apr; 33(3):157-61. PubMed ID: 15798670
[TBL] [Abstract][Full Text] [Related]
16. Cost and outcomes of nosocomial bloodstream infections complicating major traumatic injury.
Niven DJ; Fick GH; Kirkpatrick AW; Grant V; Laupland KB
J Hosp Infect; 2010 Dec; 76(4):296-9. PubMed ID: 20705364
[TBL] [Abstract][Full Text] [Related]
17. [Estimation of costs attributable to nosocomial infection: prolongation of hospitalization and calculation of alternative costs].
Peña C; Pujol M; Pallarés R; Corbella X; Vidal T; Tortras N; Ariza J; Gudiol F
Med Clin (Barc); 1996 Mar; 106(12):441-4. PubMed ID: 8656728
[TBL] [Abstract][Full Text] [Related]
18. A hospital perspective on the cost-effectiveness of beta-blockade for prophylaxis of atrial fibrillation after cardiothoracic surgery.
Gillespie EL; White CM; Kluger J; Sahni J; Gallagher R; Coleman CI
Clin Ther; 2005 Dec; 27(12):1963-9. PubMed ID: 16507383
[TBL] [Abstract][Full Text] [Related]
19. Nosocomial blood-stream infection in patients with end-stage renal disease: excess length of hospital stay, extra cost and attributable mortality.
Liu JW; Su YK; Liu CF; Chen JB
J Hosp Infect; 2002 Mar; 50(3):224-7. PubMed ID: 11886200
[TBL] [Abstract][Full Text] [Related]
20. Hospital economic impact of an outbreak of Pseudomonas aeruginosa infections.
Bou R; Lorente L; Aguilar A; Perpiñán J; Ramos P; Peris M; Gonzalez D
J Hosp Infect; 2009 Feb; 71(2):138-42. PubMed ID: 18799237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]